Ryaltris Spray, Metered
Product Images NDC 59467-700

20 FDA label images from Hikma Specialty Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Ryaltris (NDC 59467-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Specialty Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structureolopatadine (Structureolopatadine)

Structureolopatadine (Structureolopatadine)
Chemical structure of olopatadine hydrochloride, showing its molecular arrangement including aromatic rings and functional groups, consistent with the active ingredient olopatadine hydrochloride in Ryaltris nasal spray.*
FDA Label Image

Structuremometasone (Structuremometasone)

Structuremometasone (Structuremometasone)
Chemical structure of olopatadine hydrochloride and mometasone furoate, displayed as a molecular diagram including atoms such as chlorine, carbon, oxygen, hydrogen, and a water molecule (H2O). The structure shows multiple ring systems and functional groups characteristic of the active ingredients in Ryaltris nasal spray.*
FDA Label Image
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
Illustration of the Ryaltris metered nasal spray device showing labeled parts including the purple dust cap, spray nozzle tip, spray nozzle unit with finger rest, and the bottle. The bottle label identifies Ryaltris nasal spray with olopatadine hydrochloride and mometasone furoate as active ingredients and a strength of 665 mcg/25 mcg per spray.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
Ryaltris nasal spray, a metered-dose bottle held by hands removing the cap. The label shows the active ingredients olopatadine hydrochloride and mometasone furoate, with a strength of 665 mcg/25 mcg per spray. The bottle contains 240 metered sprays, with a 31 g net fill weight. The labeler is HIKMA SPECIALTY USA INC.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
Ryaltris nasal spray bottle held in a hand, labeled with active ingredients olopatadine hydrochloride and mometasone furoate. The label indicates a strength of 665 mcg/25 mcg per spray, with 240 metered sprays and a net fill weight of 31 g. The product is a metered nasal spray by Hikma Specialty USA Inc.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
Black and white illustration of a person holding a tissue to their nose, appearing to blow or wipe it. The image depicts nasal use or nasal symptoms, relevant to nasal spray products.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
Ryaltris nasal spray bottle held between thumb and forefinger, labeled with active ingredients olopatadine hydrochloride and mometasone furoate. Strength is 665 mcg/25 mcg per spray, containing 240 metered sprays with 31 g net fill weight. Label includes NDC 59467, produced by Hikma Specialty USA Inc.*
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
Black and white instructional photo showing a woman holding a nasal spray bottle close to her nostril with one hand and gently pressing the side of her nose with the other, demonstrating how to use a nasal spray product.*
FDA Label Image

Figure-g (Figure G)

Figure-g (Figure G)
An instructional illustration showing a woman using Ryaltris nasal spray. She holds the white metered spray bottle labeled with product information close to her nose, pointing one finger at her nostril, demonstrating the proper position for nasal spray administration.*
FDA Label Image

Figure-h (Figure H)

Figure-h (Figure H)
An illustration showing two hands cleaning the nozzle of a Ryaltris nasal spray bottle with a tissue. The spray bottle label displays the product name Ryaltris, active ingredients olopatadine hydrochloride and mometasone furoate, dosage form nasal spray, strength 665 mcg/25 per spray, and package count 240 metered sprays.*
FDA Label Image

Figure-i (Figure I)

Figure-i (Figure I)
The image shows a white nasal spray bottle of Ryaltris containing olopatadine hydrochloride and mometasone furoate, labeled as 665 mcg/25 mcg per spray. The bottle indicates it has 240 metered sprays with a net fill weight of 31 g and is designed for human prescription use. The spray features a removable dark-colored cap and is labeled by Hikma Specialty USA Inc.*
FDA Label Image

Figure-j (Figure J)

Figure-j (Figure J)
Instructional image showing a bottle of Ryaltris nasal spray with a spray nozzle tip. The text advises not to pierce the spray nozzle tip, depicted by a diagonal line crossing out a pointed object aimed at the nozzle. The background is dark with white text and illustration.*
FDA Label Image

Figure-k (Figure K)

Figure-k (Figure K)
Ryaltris nasal spray bottle labeled with active ingredients olopatadine hydrochloride and mometasone furoate. The label indicates a strength of 665 mcg/25 mcg per spray, with 240 metered sprays and a net fill weight of 31 g. The spray pump is being attached to the bottle, held by two hands.*
FDA Label Image

Figure-l (Figure L)

Figure-l (Figure L)
Ryaltris nasal spray, metered dosage form, with labels indicating active ingredients olopatadine hydrochloride and mometasone furoate at strengths of 665 mcg/25 mcg per spray. The image shows the spray bottle, a clear plastic cap, and a measuring cup with an insert inside. Produced by HIKMA SPECIALTY USA INC.*
FDA Label Image

Figure-m (Figure M)

Figure-m (Figure M)
An instructional image showing a hand rinsing a white nasal spray nozzle under running water from a faucet. The image likely demonstrates how to clean or maintain the spray nozzle for a nasal spray product.*
FDA Label Image

Figure-n (Figure N)

Figure-n (Figure N)
Ryaltris nasal spray bottle held by two hands. The label shows the product name Ryaltris with active ingredients olopatadine hydrochloride and mometasone furoate. The strength is 665 mcg/25 ml per spray. The bottle is white with a dark spray nozzle cap.*
FDA Label Image

Glenmarklogo2 (Glenmarklogo2)

FDA Label Image

Image1 (Image1)

Image1 (Image1)
Ryaltris nasal spray label showing active ingredients olopatadine hydrochloride and mometasone furoate with strengths of 665 mcg and 25 mcg per spray, respectively. The label includes directions to shake well before use, priming instructions, and storage recommendations. The product is distributed by Hikma Specialty USA Inc. and contains 240 metered sprays in a 31 g net fill bottle. The label features the Ryaltris logo and states it is for Rx use only.*
FDA Label Image

Image2 (Image2)

Image2 (Image2)
Packaging label for Ryaltris nasal spray 665 mcg/25 mcg per spray, containing olopatadine hydrochloride and mometasone furoate. The label shows the product name, strength, dosage form, intranasal route, and instructions for use, including dosing and cleaning procedures. The labeler is Hikma Specialty USA Inc., and the package contains 240 metered sprays with a net fill weight of 31 g. The label emphasizes shaking the bottle well before use and includes storage and safety information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.